tirzepatide 1ml 10mg (10mg/mL + Methylcobalamin 500 mcg/mL) (1mL Vial) 1ML Tirzepatide + Glycine +

Weight Loss Injection Side Effects What Science Actually Says Weight loss injection side effects have been documented in large clinical trials involving thousands of patients

Diabetes 38 , 673678 (1989)

REFRIGERATE AFTER OPENING

GLP-1 receptor agonists include medications such as semaglutide, dulaglutide, and liraglutide, which are typically administered by subcutaneous injection (though oral semaglutide is available)

Key risk factors include: Rapid weight loss: Losing weight quickly significantly increases gallstone risk Female sex: Women are two to three times more likely to develop gallstones than men Age over 40 years: Gallstone prevalence increases with age Obesity: Higher baseline BMI correlates with increased risk Previous history of gallstones: Prior biliary disease predicts recurrence Family history: Genetic factors contribute to gallstone susceptibility Certain ethnicities: Native American and Hispanic populations have higher baseline rates Estrogen exposure: Oral contraceptives, hormone replacement therapy, and multiple pregnancies Diabetes and dyslipidemia: Metabolic conditions affecting bile composition Prolonged fasting or TPN use: Reduces gallbladder contraction Patients should be educated about warning signs that may indicate gallstone complications

Alli (orlistat) EPAR Product Information (SmPC)